Navigation Links
EntreMed ENMD-2076 Phase 1 Data to Be Presented at ASCO Annual Meeting
Date:5/15/2009

ENMD-2076 Clinical Program Adds Leukemia Clinical Study and Orphan Drug Designation

ROCKVILLE, Md., May 15 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer today announced presentations for three of its clinical-stage drug candidates at the American Society of Clinical Oncology (ASCO) Annual Meeting to be held May 29 - June 2, 2009 in Orlando, Florida. Presentations include both poster and discussion sessions and are listed below.

  • Poster Session: Friday, May 29, 2009 - 2:00 p.m. - 6:00 p.m. Abstract No.: 3520, "An open-label, dose escalation, safety, and pharmacokinetic study of ENMD-2076 administered orally to patients with advanced cancer."
    • Discussion Session: Friday, May 29, 2009 - 5:00 p.m. - 5:15 p.m. "Angiogenesis Inhibitors: New Agents and New Combinations," Level 4, Valencia Room, W415D.
  • Poster Session: Saturday, May 30, 2009 - 8:00 a.m. - 12:00 p.m. Abstract No.: 3562, "A single center, open-label, dose escalation, safety, and pharmacokinetic study of ENMD-1198 administered orally to patients with advanced cancer."
  • Poster Session: Sunday, May 31, 2009 - 2:00 p.m. - 6:00 p.m. Abstract No: 5577, "Phase 2 study of MKC-1 in patients with metastatic or resistant epithelial ovarian cancer or advanced endometrial cancer."

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

The Company has furth
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. EntreMed Initiates ENMD-2076 Clinical Trial in Multiple Myeloma
2. EntreMed to Present at the New York Society of Security Analysts Industry Conference
3. EntreMeds MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial
4. EntreMed Reports Third Quarter 2008 Financial Results
5. EntreMeds ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
6. EntreMed to Present at BioPartnering Europe Conference
7. EntreMed Announces Stock Listing Transfer to Nasdaq Capital Market
8. EntreMed Reports Second Quarter 2008 Financial Results
9. EntreMed Appoints Thomas H. Bliss as Senior Vice President of Corporate and Business Development
10. Dana-Farber Cancer Institute Commences Phase 1 Trial With EntreMeds Selective Kinase Inhibitor
11. EntreMed Will Not Seek Shareholder Approval for Reverse Stock Split at Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... ANN ARBOR, Mich. , May 6, 2015 ... Penny , CEO will give the keynote address at ... 2015 Annual Meeting in Phoenix, AZ ... talk, entitled "Personalized Medicine: The Odyssey" will focus on the ... past ten years in shaping our personalized medicine revolution.  ...
(Date:5/6/2015)... May 6, 2015  Endo International plc (NASDAQ: ENDP ... , President and CEO, will present a corporate overview at ... City on Wednesday, May 20, 2015 at 11:00 ... archive for the event will be available on the Company,s ... then the link to the event. Participants should allow approximately ...
(Date:5/6/2015)... New Columbia, PA (PRWEB) May 06, 2015 ... of the most comprehensive lines of standard and custom ... industry. Known for its innovative engineering and design, robust ... test chambers is designed to meet all of your ... pleased to announce the addition of the TPS Smart ...
(Date:5/6/2015)... BETHESDA, Md. , May 6, 2015  Northwest Biotherapeutics ... personalized immune therapies for solid tumor cancers, today announced that ... overview of the Company,s DCVax cancer vaccine platform for solid ... on May 7, 2015.   , ... , , , , TIME: , , , 12:15 ...
Breaking Biology Technology:Paradigm CEO Dr. Robert Penny Presents Keynote Address at 2015 ISBER Conference 2Paradigm CEO Dr. Robert Penny Presents Keynote Address at 2015 ISBER Conference 3The TPS 3.5” Smart 1.0 Controller Raises the Tech Standard on Environmental Test Chambers 2NW Bio To Webcast, Live, at VirtualInvestorConferences.com On May 7 2NW Bio To Webcast, Live, at VirtualInvestorConferences.com On May 7 3
... announced today the appointment of Peter Allen to ... this position, Mr. Allen,will assume responsibility for global ... his current responsibilities as President,Donor Division., Brian ... an,architect of our strategic vision to be the ...
... CEO of The,BioAnalytics Group LLC and Ned Haubein, ... Symposium on March 12-13, 2008. The,symposium, subtitled, "Driving ... will be attended by hundreds of,scientists and executives ... Dr. Lett,s invited presentation will focus on developing ...
... BSX ) is scheduled to participate in the ... 18 - 20 in Miami,Florida., Paul LaViolette, Chief ... 18, beginning at approximately 9:00 a.m.,E.T. Sam Leno, Executive ... in a question and answer session., A live ...
Cached Biology Technology:Haemonetics(R) Appoints Peter Allen as Chief Marketing Officer 2BioAnalytics Group CEO, Senior Scientist to Present at Tucson Symposium March 12-13 2
(Date:4/2/2015)... , April 2, 2015 ... tests DERMALOG by far outperforms the strongest competitors, ... maintaining high accuracy, the system is capable of ... the speed proves up to be ten times ... than its runner-up performance.      (Photo: ...
(Date:4/1/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces the second shipment of ... to early access pre-order customers. Feedback ... outlets including Walmart, Target, AT&T, Dunkin, Donuts, Stop & ... at all outlets and very easy to use. Several ...
(Date:3/30/2015)... and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) has announced ... in Automotive Sector 2014-2018" report to their offering. ... market in Automotive Sector to grow at a CAGR ... recognition is the ability of a device to identify ... recognition technology can be 2D-based or 3D-based. It uses ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... things better adapt to climate change, especially when genes flow ... Davis study of the Sierra Nevada cutleaved monkeyflower. The results ... of the National Academy of Sciences . The findings ... evolution and ecology at UC Davis and an author of ...
... from a diverse range of fields discussed the promise of ... organisms -- progress that may one day lead to new ... participants have joined in a discussion of the issues and ... Mathematics and Applied Physics at the School of Engineering and ...
... 28, 2011 -- The evaluation of both nutrient ... sustainably manage agroforestry systems. Improved diagnosis of appropriate ... reduce financial and environmental costs. To achieve this, ... evaluation of nutrient-production imbalances is needed. Scientists ...
Cached Biology News:Gene flow may help plants adapt to climate change 2Beyond Darwin: Evolving new functions 2Analyzing agroforestry management 2
A Highly Purified, Cost-Effective Taq DNA Polymerase...
...
... immunosorbent assay (ELISA) test kits are ... for the detection of drugs and/or their ... intended for forensic use only. It is ... by a quantitative method such as GC/MS. ...
96 Well Base Plate...
Biology Products: